期刊
INFLAMMATION
卷 42, 期 4, 页码 1147-1159出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10753-019-01008-y
关键词
inflammatory bowel disease; NLRP3 inflammasome; ulcerative colitis; Crohn's disease; inflammation; autophagy
资金
- National Key R&D Program of China [2017YFC1308800, 2018YFC1313103]
- National Natural Science Foundation of China [81800489]
- Three Engineering Training Funds in Shenzhen [SYLY201718]
- Three engineering training funds in Shenzhen [SYLY201718]
- Technical Research and Development Project of Shenzhen [JCYJ20150403101028164, JCYJ20170307100538697]
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine, comprised of ulcerative colitis and Crohn's disease. Among the complicated pathogenic factors of IBD, the overaction of inflammatory and immune reaction serves as an important factor. Inflammasome is a form of innate immunity as well as inflammation. Among all kinds of inflammasomes, the NOD-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome is the most studied one, and has been revealed to be involved in the pathogenesis and progression of IBD. Here, in this review, the association between the NLRP3 inflammasome and IBD will be discussed. Furthermore, several NLRP3 inflammasome inhibitors which have been demonstrated to be effective in the alleviation of IBD will be described in this review.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据